z-logo
open-access-imgOpen Access
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women
Author(s) -
Annaléne Nel,
Neliëtte van Niekerk,
Saidi Kapiga,
LindaGail Bekker,
Cynthia Gama,
Katherine Gill,
Anatoli Kamali,
Philip Kotze,
Cheryl Louw,
Zonke Mabude,
Nokuthula Miti,
Sylvia Kusemererwa,
Hugo Tempelman,
Hannelie Carstens,
Bríd Devlin,
Michelle Isaacs,
Mariëtte Malherbe,
Winél Mans,
Jeremy Nuttall,
Marisa Russell,
Smangaliso Ntshele,
Marlie Smit,
Leonard Nichiren Solai,
Patrick Spence,
John Steytler,
Kathleen Marie Windle,
Maarten Borremans,
Sophie Resseler,
Jens Van Roey,
Wim Parys,
Tony Vangeneugden,
Ben Van Baelen,
Zeda Rosenberg
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1602046
Subject(s) - medicine , seroconversion , hazard ratio , placebo , confidence interval , vaginal ring , incidence (geometry) , gynecology , obstetrics , human immunodeficiency virus (hiv) , population , family planning , immunology , physics , environmental health , optics , research methodology , alternative medicine , pathology
The incidence of human immunodeficiency virus (HIV) infection remains high among women in sub-Saharan Africa. We evaluated the safety and efficacy of extended use of a vaginal ring containing dapivirine for the prevention of HIV infection in 1959 healthy, sexually active women, 18 to 45 years of age, from seven communities in South Africa and Uganda.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom